These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36964657)

  • 21. T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research.
    Chen Z; Ruan P; Wang L; Nie X; Ma X; Tan Y
    J Cell Mol Med; 2021 Jan; 25(2):1274-1289. PubMed ID: 33325143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
    Carstens C; Newman DK; Bohlen H; König A; Koch N
    Int Immunol; 2000 Nov; 12(11):1561-8. PubMed ID: 11058576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular dynamics simulations to provide insights into epitopes coupled to the soluble and membrane-bound MHC-II complexes.
    Bello M; Correa-Basurto J
    PLoS One; 2013; 8(8):e72575. PubMed ID: 23977319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes at the floor of the peptide-binding groove induce a strong preference for proline at position 3 of the bound peptide: molecular dynamics simulations of HLA-A*0217.
    Toh H; Savoie CJ; Kamikawaji N; Muta S; Sasazuki T; Kuhara S
    Biopolymers; 2000 Oct; 54(5):318-27. PubMed ID: 10935972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-resolution profiling of MHC II peptide presentation capacity reveals SARS-CoV-2 CD4 T cell targets and mechanisms of immune escape.
    Obermair FJ; Renoux F; Heer S; Lee CH; Cereghetti N; Loi M; Maestri G; Haldner Y; Wuigk R; Iosefson O; Patel P; Triebel K; Kopf M; Swain J; Kisielow J
    Sci Adv; 2022 Apr; 8(17):eabl5394. PubMed ID: 35486722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.
    Chornoguz O; Gapeev A; O'Neill MC; Ostrand-Rosenberg S
    Mol Cell Proteomics; 2012 Nov; 11(11):1457-67. PubMed ID: 22942358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigen presentation by MHC class II molecules.
    Weenink SM; Gautam AM
    Immunol Cell Biol; 1997 Feb; 75(1):69-81. PubMed ID: 9046437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MHC class II complexes sample intermediate states along the peptide exchange pathway.
    Wieczorek M; Sticht J; Stolzenberg S; Günther S; Wehmeyer C; El Habre Z; Álvaro-Benito M; Noé F; Freund C
    Nat Commun; 2016 Nov; 7():13224. PubMed ID: 27827392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strict Assembly Restriction of Peptides from Rabbit Hemorrhagic Disease Virus Presented by Rabbit Major Histocompatibility Complex Class I Molecule RLA-A1.
    Zhang Q; Liu K; Yue C; Zhang D; Lu D; Xiao W; Liu P; Zhao Y; Gao G; Ding C; Lyu J; Liu WJ
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32522857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational variation in structures of classical and non-classical MHCII proteins and functional implications.
    Painter CA; Stern LJ
    Immunol Rev; 2012 Nov; 250(1):144-57. PubMed ID: 23046127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.
    Bhayani H; Paterson Y
    J Exp Med; 1989 Nov; 170(5):1609-25. PubMed ID: 2553848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding interactions between peptides and proteins of the class II major histocompatibility complex.
    McFarland BJ; Beeson C
    Med Res Rev; 2002 Mar; 22(2):168-203. PubMed ID: 11857638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting Class II MHC-Peptide binding: a kernel based approach using similarity scores.
    Salomon J; Flower DR
    BMC Bioinformatics; 2006 Nov; 7():501. PubMed ID: 17105666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation.
    Gregers TF; Fleckenstein B; Vartdal F; Roepstorff P; Bakke O; Sandlie I
    Int Immunol; 2003 Nov; 15(11):1291-9. PubMed ID: 14565927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A previously unappreciated polymorphism in the beta chain of I-A
    Richards KA; Lavery C; Keller GLJ; Miller J; Baker BM; Sant AJ
    Mol Immunol; 2022 Mar; 143():17-26. PubMed ID: 34995990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ii-Key/MHC class II epitope peptides as helper T cell vaccines for cancer and infectious disease.
    Kallinteris NL; Powell D; Blackwell CE; Kim M; Lu X; Wu S; Humphreys RE; Xu M; von Hofe E
    Front Biosci; 2006 Jan; 11():46-58. PubMed ID: 16146713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural requirements for binding of myelin basic protein (MBP) peptides to MHC II: effects on immune regulation.
    Mantzourani ED; Mavromoustakos TM; Platts JA; Matsoukas JM; Tselios TV
    Curr Med Chem; 2005; 12(13):1521-35. PubMed ID: 15974985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular modeling of hen egg lysozyme HEL[52-61] peptide binding to I-Ak MHC class II molecule.
    Weber P; Raynaud I; Ettouati L; Trescol-Biémont MC; Carrupt PA; Paris J; Rabourdin-Combe C; Gerlier D; Testa B
    Int Immunol; 1998 Dec; 10(12):1753-64. PubMed ID: 9885896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for invariant chain 85-101 (CLIP) binding in the antigen binding site of MHC class II molecules.
    Bangia N; Watts TH
    Int Immunol; 1995 Oct; 7(10):1585-91. PubMed ID: 8562503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.